1 March 2023 - Eli Lilly today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out of pocket costs at $35 or less per month.
Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex health care system that may keep them from getting affordable insulin.